KRR1, Small Subunit (SSU) Processome Component, Homolog (HIV-1 Rev Binding Protein 2, HRB2, RIP-1)

437 EUR

50ug

GEN603188

hiv

N/A

IgG1

8C208

Antibodies

Monoclonal

Western Blot (WB)

KRR1, Small Subunit

Mnoclonal antibodies

Human (Homo sapiens)

Mouse (Mus musculus)

KRR1; KRR1; HRB2; RIP-1; HRB2

KRR1; KRR1; HRB2; RIP-1; HRB2

KRR1; KRR1; HRB2; RIP-1; HRB2

Affinity Purified by Protein G affinity chromatography.

Supplied as a sterile-filtered liquid in PBS, pH 7.4, 1% BSA, 0.05% sodium azide.

Human (Homo sapiens); Due to limited knowledge and inability for testing each and every species, the reactivity of the antibody may extend to other species which are not listed hereby.

Recognizes human KRR1, Small Subunit (SSU) Processome Component, Homolog.; Since it is not possible to test each and every species our knowledge on the corss reactivity of the antibodies is limited. This particular antibody might cross react with speacies outside of the listed ones.

KRR1 small subunit processome component homolog; KRR1 small subunit processome component homolog; KRR1 small subunit processome component homolog; Rev interacting protein; rev-interacting protein 1; HIV-1 Rev binding protein 2; HIV-1 Rev-binding protein 2; KRR1, small subunit (SSU) processome component, homolog (yeast); HIV-1 Rev-binding protein 2; Rev-interacting protein 1

Store the antibody at +4 degrees Celsius for short term storage.. For long-term storage and to avoid repeated freezing and thawing, add sterile 40-50% glycerol, aliquot and For optimal long term storage, the antibody should be kept at -20 degrees Celsius. Aliquots are stable for at least 12 months the antibody should be stored at -20 degrees Celsius.. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

The human immunodeficiency virus (HIV) is a lentivirus (a subgroup of retrovirus) that causes HIV infection and over time acquired immunodeficiency syndrome(AIDS). AIDS is a condition in humans in which progressive failure of the immune system allows life-threatening opportunistic infections and cancers to thrive. Without treatment, average survival time after infection with HIV is estimated to be 9 to 11 years, depending on the HIV subtype. Infection with HIV occurs by the transfer of blood, semen, vaginal fluid, pre-ejaculate, or breast milk. Within these bodily fluids, HIV is present as both free virus particles and virus within infected immune cells. recombinant HIV 1 and 2 gag gene proteins p24, p17, p55 immunodominant epitopes and envelope glycoproteins, gp120 are used for production of diagnostic detection antibodies.